STORZ MEDICAL – Literature Databases
STORZ MEDICAL – Literature Databases
Literature Databases
Literature Databases

Extracorporeal Magnetotransduction Therapy (EMTT): STORZ MEDICAL’s MAGNETOLITH receives 510(k) clearance from the FDA

MAGNETOLITH_002

On 3 May 2021, STORZ MEDICAL received the 510(k) clearance for the MAGNETOLITH® from the U.S. Food and Drug Administration (FDA). The therapy device is now cleared in the USA (as a class II medical device) for the following indications:

  • Relaxation of muscle spasms
  • Prevention or retardation of disuse atrophy
  • Increase local blood circulation
  • Muscle re-education
  • Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis
  • Maintaining or increasing range of motion
Continue reading
0
  4387 Hits